HomePink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

China
FDA
EU Regulatory Reform
AI
Cell & Gene Therapy
Interviews

Policy & Regulation

Product Reviews
IP & Litigation
Drug Safety
Regulatory Pathways
Legislation

Market Access

HTA
PBMs
Medicaid
Medicare

Regions

Cross-Agency Comparisons
Asia
North America
Europe
Latin America
Middle East & Africa
Global Guidance Tracker

FDA Tools & Trackers

User Fee Goal Dates
Novel Approvals
Designations
Complete Response Letters
US Biosimilars
Advisory Committee Meetings

EMA Tools & Trackers

EU Filings
CHMP Opinions
EU Approvals
Accelerated Assessment
EU Biosimilars
PRIME Scheme

Conference Coverage

Partner Insights

Pink Sheet Perspectives

Previewing major regulatory, market access and political themes.

Medtech Insight

Generics Bulletin

EU 2019 Approvals: Novel Therapies Make Strong Showing

Firsts Include Ebola Vaccine And Tumor Agnostic Therapy

Jan 14 2020

• By Ian Schofield

Pink Sheet Perspectives 2019 to 2020 — 2019 saw the EU approval of several new innovative drugs

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

Additional Topics

Europe Approvals Regulation BioPharmaceutical Pink Sheet Perspectives

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Regulatory Trackers
Pink Sheet Perspectives
Regional Comparisons
Drug Review Profiles

Terms and Conditions Opens in new window

Privacy PolicyOpens in new window